Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rotavirus vaccine 116E - Bharat Biotech

Drug Profile

Rotavirus vaccine 116E - Bharat Biotech

Alternative Names: 116E - Bharat Biotech; Oral Rotavirus Vaccine 116E Live Attenuated - Bharat Biotech; ORV-116E; Rotavac; Rotavac - Bharat Biotech; ROTAVAC 5C; ROTAVAC 5C -F1; ROTAVAC 5C -F2; ROTAVAC 5CM; ROTAVAC 5D®; ROTAVAC®-20; Vero cell-based 116E neonatal rotavirus vaccine - Bharat Biotech

Latest Information Update: 16 Jan 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bharat Biotech
  • Class Rotavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rotavirus infections

Most Recent Events

  • 07 Jul 2023 Phase-III clinical trials in Rotavirus infections (In infants, Prevention) in Chile (PO) (NCT06200844)
  • 24 Aug 2022 Launched for Rotavirus infections (In children, Prevention) in Nigeria (PO)
  • 16 Apr 2021 Launched for Rotavirus infections (In infants, Prevention) in Vietnam (PO) prior to April 2021
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top